Operating Income Summary of Amgen Inc.

Amgen Inc.'s latest annual operating income in 2023 was 7.89 Billion USD , up 48.02% from previous year.
Amgen Inc.'s latest quarterly operating income in 2024 Q3 was 2.04 Billion USD , up 10.41% from previous quarter.
Amgen Inc. reported an annual operating income of 5.33 Billion USD in 2022, down -11.16% from previous year.
Amgen Inc. reported an annual operating income of 6 Billion USD in 2021, up 3.64% from previous year.
Amgen Inc. reported a quarterly operating income of 1.85 Billion USD for 2024 Q2, up 97.23% from previous quarter.
Amgen Inc. reported a quarterly operating income of 2.04 Billion USD for 2024 Q3, up 10.41% from previous quarter.

Annual Operating Income Chart of Amgen Inc. (2023 - 1990)

Historical Annual Operating Income of Amgen Inc. (2023 - 1990)

Year	Operating Income	Operating Income Growth
2023	7.89 Billion USD	48.02%
2022	5.33 Billion USD	-11.16%
2021	6 Billion USD	3.64%
2020	5.79 Billion USD	-40.11%
2019	9.67 Billion USD	-5.74%
2018	10.26 Billion USD	2.91%
2017	9.97 Billion USD	1.83%
2016	9.79 Billion USD	15.63%
2015	8.47 Billion USD	36.81%
2014	6.19 Billion USD	5.52%
2013	5.86 Billion USD	5.2%
2012	5.57 Billion USD	29.34%
2011	4.31 Billion USD	-22.24%
2010	5.54 Billion USD	0.71%
2009	5.5 Billion USD	5.6%
2008	5.21 Billion USD	31.01%
2007	3.98 Billion USD	3.65%
2006	3.84 Billion USD	-20.79%
2005	4.84 Billion USD	44.8%
2004	3.34 Billion USD	8.31%
2003	3.09 Billion USD	-50.99%
2002	6.3 Billion USD	311.93%
2001	1.53 Billion USD	11.92%
2000	1.36 Billion USD	3.25%
1999	1.32 Billion USD	18.47%
1998	1.11 Billion USD	20.22%
1997	930.3 Million USD	1.56%
1996	916 Million USD	20.4%
1995	760.8 Million USD	8.92%
1994	698.5 Million USD	26.72%
1993	551.2 Million USD	10.66%
1992	498.1 Million USD	303.65%
1991	123.4 Million USD	324.05%
1990	29.1 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	940 Million USD	-26.04%
2024 Q2	1.85 Billion USD	97.23%
2024 Q3	2.04 Billion USD	10.41%
2023 Q1	3.08 Billion USD	146.41%
2023 Q4	1.27 Billion USD	-37.11%
2023 Q3	2.02 Billion USD	-24.7%
2023 Q2	2.68 Billion USD	-13.0%
2023 FY	7.89 Billion USD	48.02%
2022 Q1	1.12 Billion USD	-51.0%
2022 Q2	2.17 Billion USD	92.74%
2022 Q4	1.25 Billion USD	-34.89%
2022 FY	5.33 Billion USD	-11.16%
2022 Q3	1.92 Billion USD	-11.63%
2021 Q4	2.3 Billion USD	-3.11%
2021 FY	6 Billion USD	3.64%
2021 Q1	2.12 Billion USD	6.03%
2021 Q2	828 Million USD	-61.11%
2021 Q3	2.37 Billion USD	187.2%
2020 Q2	2.32 Billion USD	-1.36%
2020 Q3	2.45 Billion USD	5.6%
2020 Q4	2 Billion USD	-18.14%
2020 Q1	2.35 Billion USD	14.99%
2020 FY	5.79 Billion USD	-40.11%
2019 Q2	2.67 Billion USD	8.33%
2019 FY	9.67 Billion USD	-5.74%
2019 Q4	2.04 Billion USD	-17.29%
2019 Q3	2.47 Billion USD	-7.54%
2019 Q1	2.47 Billion USD	3.78%
2018 Q3	2.32 Billion USD	-17.97%
2018 FY	10.26 Billion USD	2.91%
2018 Q1	2.72 Billion USD	21.43%
2018 Q4	2.38 Billion USD	2.54%
2018 Q2	2.83 Billion USD	3.89%
2017 Q4	2.24 Billion USD	-7.95%
2017 FY	9.97 Billion USD	1.83%
2017 Q1	2.59 Billion USD	4.27%
2017 Q2	2.69 Billion USD	4.13%
2017 Q3	2.43 Billion USD	-9.6%
2016 Q1	2.4 Billion USD	18.15%
2016 FY	9.79 Billion USD	15.63%
2016 Q4	2.48 Billion USD	-1.66%
2016 Q3	2.52 Billion USD	6.18%
2016 Q2	2.38 Billion USD	-0.92%
2015 Q2	2.07 Billion USD	2.67%
2015 FY	8.47 Billion USD	36.81%
2015 Q1	2.02 Billion USD	38.59%
2015 Q3	2.33 Billion USD	12.67%
2015 Q4	2.03 Billion USD	-13.08%
2014 Q4	1.45 Billion USD	-0.48%
2014 Q1	1.36 Billion USD	14.91%
2014 FY	6.19 Billion USD	5.52%
2014 Q3	1.46 Billion USD	-22.92%
2014 Q2	1.9 Billion USD	39.44%
2013 FY	5.86 Billion USD	5.2%
2013 Q4	1.18 Billion USD	-29.68%
2013 Q2	1.55 Billion USD	7.49%
2013 Q1	1.44 Billion USD	32.54%
2013 Q3	1.68 Billion USD	8.9%
2012 Q1	1.47 Billion USD	27.11%
2012 Q3	1.42 Billion USD	-10.45%
2012 FY	5.57 Billion USD	29.34%
2012 Q4	1.08 Billion USD	-23.54%
2012 Q2	1.58 Billion USD	7.58%
2011 Q3	525 Million USD	-60.59%
2011 Q4	1.16 Billion USD	121.33%
2011 Q1	1.29 Billion USD	21.07%
2011 FY	4.31 Billion USD	-22.24%
2011 Q2	1.33 Billion USD	3.02%
2010 Q4	1.06 Billion USD	-27.79%
2010 Q2	1.51 Billion USD	2.43%
2010 Q3	1.47 Billion USD	-2.5%
2010 FY	5.54 Billion USD	0.71%
2010 Q1	1.48 Billion USD	31.88%
2009 Q3	1.6 Billion USD	10.16%
2009 Q1	1.32 Billion USD	16.18%
2009 FY	5.5 Billion USD	5.6%
2009 Q2	1.45 Billion USD	10.3%
2009 Q4	1.12 Billion USD	-30.03%
2008 FY	5.21 Billion USD	31.01%
2008 Q3	1.48 Billion USD	25.78%
2008 Q4	1.13 Billion USD	-23.33%
2008 Q1	1.41 Billion USD	33.87%
2008 Q2	1.17 Billion USD	-16.68%
2007 FY	3.98 Billion USD	3.65%
2007 Q1	1.4 Billion USD	41.56%
2007 Q2	1.13 Billion USD	-19.29%
2007 Q4	1.05 Billion USD	168.96%
2007 Q3	393 Million USD	-65.22%
2006 Q3	1.32 Billion USD	348.14%
2006 Q1	1.23 Billion USD	12.08%
2006 FY	3.84 Billion USD	-20.79%
2006 Q4	989 Million USD	-25.19%
2006 Q2	295 Million USD	-76.09%
2005 FY	4.84 Billion USD	44.8%
2005 Q3	1.29 Billion USD	0.39%
2005 Q2	1.29 Billion USD	11.85%
2005 Q1	1.15 Billion USD	25.79%
2005 Q4	1.1 Billion USD	-15.18%
2004 Q2	1 Billion USD	8.47%
2004 Q4	919 Million USD	86.03%
2004 FY	3.34 Billion USD	8.31%
2004 Q3	494 Million USD	-50.93%
2004 Q1	928.1 Million USD	22.91%
2003 Q2	817.1 Million USD	23.39%
2003 Q4	755.1 Million USD	-11.87%
2003 Q1	662.2 Million USD	-91.45%
2003 Q3	856.8 Million USD	4.86%
2003 FY	3.09 Billion USD	-50.99%
2002 Q1	457.4 Million USD	118.75%
2002 Q4	7.74 Billion USD	415.02%
2002 FY	6.3 Billion USD	311.93%
2002 Q3	-2.45 Billion USD	-535.22%
2002 Q2	564.8 Million USD	23.48%
2001 Q3	456.2 Million USD	1.51%
2001 Q4	209.1 Million USD	-54.16%
2001 Q2	449.4 Million USD	7.9%
2001 FY	1.53 Billion USD	11.92%
2001 Q1	416.5 Million USD	40.9%
2000 Q4	295.6 Million USD	-23.74%
2000 FY	1.36 Billion USD	3.25%
2000 Q3	387.6 Million USD	8.18%
2000 Q2	358.3 Million USD	9.71%
2000 Q1	326.6 Million USD	-1.21%
1999 Q1	302 Million USD	1.34%
1999 Q3	355.6 Million USD	5.58%
1999 FY	1.32 Billion USD	18.47%
1999 Q4	330.6 Million USD	-7.03%
1999 Q2	336.8 Million USD	11.52%
1998 Q3	292.8 Million USD	3.54%
1998 FY	1.11 Billion USD	20.22%
1998 Q4	298 Million USD	1.78%
1998 Q1	244.8 Million USD	9.87%
1998 Q2	282.8 Million USD	15.52%
1997 Q4	222.8 Million USD	2.53%
1997 Q3	217.3 Million USD	-16.1%
1997 Q2	259 Million USD	12.02%
1997 Q1	231.2 Million USD	-1.41%
1997 FY	930.3 Million USD	1.56%
1996 Q2	252.7 Million USD	29.99%
1996 Q4	234.5 Million USD	0.04%
1996 FY	916 Million USD	20.4%
1996 Q1	194.4 Million USD	-3.14%
1996 Q3	234.4 Million USD	-7.24%
1995 Q4	200.7 Million USD	-3.56%
1995 FY	760.8 Million USD	8.92%
1995 Q2	194.9 Million USD	24.06%
1995 Q1	157.1 Million USD	-17.45%
1995 Q3	208.1 Million USD	6.77%
1994 Q1	151.2 Million USD	9.64%
1994 FY	698.5 Million USD	26.72%
1994 Q4	190.3 Million USD	3.37%
1994 Q3	184.1 Million USD	6.42%
1994 Q2	173 Million USD	14.42%
1993 Q2	139.7 Million USD	11.85%
1993 Q3	148.8 Million USD	6.51%
1993 Q4	137.9 Million USD	-7.33%
1993 FY	551.2 Million USD	10.66%
1993 Q1	124.9 Million USD	-36.95%
1992 Q3	118.7 Million USD	22.5%
1992 Q4	198.1 Million USD	66.89%
1992 Q1	84.4 Million USD	3.05%
1992 FY	498.1 Million USD	303.65%
1992 Q2	96.9 Million USD	14.81%
1991 Q1	51.9 Million USD	274.16%
1991 Q3	63.7 Million USD	185.85%
1991 Q4	81.9 Million USD	28.57%
1991 FY	123.4 Million USD	324.05%
1991 Q2	-74.2 Million USD	-242.97%
1990 FY	29.1 Million USD	0.0%
1990 Q1	10.6 Million USD	-9.4%
1990 Q2	13.4 Million USD	26.42%
1990 Q4	-29.8 Million USD	-291.03%
1990 Q3	15.6 Million USD	16.42%
1989 Q2	1.7 Million USD	102.71%
1989 Q1	-62.8 Million USD	-394.84%
1989 Q4	11.7 Million USD	138.78%
1989 Q3	4.9 Million USD	188.24%

Peer Operating Income Comparison of Amgen Inc.

Name	Operating Income	Operating Income Difference
AstraZeneca PLC	8.19 Billion USD	3.613%
Biogen Inc.	1.29 Billion USD	-508.961%
Gilead Sciences, Inc.	7.6 Billion USD	-3.84%
MIRA Pharmaceuticals, Inc.	-8.52 Million USD	92722.023%
Scilex Holding Company	-105.43 Million USD	7590.207%
Scilex Holding Company	-105.43 Million USD	7590.207%

Global Stocks Search

Amgen Inc. (AMGN)

Operating Income Summary of Amgen Inc.

Annual Operating Income Chart of Amgen Inc. (2023 - 1990)

Historical Annual Operating Income of Amgen Inc. (2023 - 1990)

Peer Operating Income Comparison of Amgen Inc.